May 28, 2008 - SNM’s 55th Annual Meeting, “Molecular Imaging: Build on the Past, Define the Future,” will be held June 14–18, 2008, in New Orleans, LA, unveiling new research in the molecular imaging, neurology, cardiology and oncology fields that may directly affect the future of patient care.

Topics of discussion include the use of PET, SPECT and other forms of imaging to detect and diagnose Alzheimer’s disease and other dementias; predict sudden cardiac death; view spinal cord injuries; advance the diagnosis of ovarian and prostate cancer and study post-menopausal women.

A press conference will be held Monday, June 16, from 11:30 a.m.–12:30 p.m., to discuss specific research topics. During the press conference, Dr. Henry Wagner, Johns Hopkins University, will reveal the highly anticipated “SNM Image of the Year.” Other portions of the annual meeting open to media include plenary sessions, categorical seminars, the exhibit hall and presentations of scientific papers and posters.

For more information: www.snm.org/am


Related Content

News | Radiopharmaceuticals and Tracers

Oct. 19, 2026 — Nuclidium AG, a clinical-stage radiopharmaceutical company, and NorthStar Medical Technologies, a global ...

Time October 19, 2026
arrow
News | Molecular Imaging

Oct. 15, 2026 — GE HealthCare has announced that its MINItrace Magni cyclotron has achieved CE Mark and that its ...

Time October 16, 2026
arrow
News | Information Technology

October 6, 2026 – Clearsense has introduced a cloud-based medical image archive designed to reduce the cost of ...

Time October 07, 2026
arrow
News | Radiopharmaceuticals and Tracers

Oct. 5, 2026 — GE HealthCare has announced a definitive agreement to acquire SOFIE Biosciences, a U.S.-based CMO for PET ...

Time October 06, 2026
arrow
News | PET-MRI

Sept. 29, 2026 —Yale New Haven Hospital has installed a state-of-the-art positron emission tomography/magnetic resonance ...

Time October 05, 2026
arrow
News | Radiopharmaceuticals and Tracers

Aug. 30, 2026 — Bayer has announced the presentation of first detailed results from the Phase III REVEAL study, an ...

Time September 02, 2026
arrow
News | Radiation Oncology

July 8, 2026 — GE HealthCare and Mayo Clinic have announced the MI-BET (Molecular Imaging Biomarker-Based End of Therapy ...

Time July 09, 2026
arrow
News | PET-MRI

June 10, 2026 — UTHealth Houston has launched a state-of-the-art PET/MRI imaging service, bringing together two advanced ...

Time June 12, 2026
arrow
News | Nuclear Imaging

June 1, 2026 — At the 2026 Society of Nuclear Medicine and Molecular Imaging (SNMMI) annual meeting, GE HealthCare will ...

Time June 02, 2026
arrow
News | Radiopharmaceuticals and Tracers

May 27, 2026 — Subtle Medical has received FDA clearance for its SubtleHD (PET), the company's next-generation AI ...

Time May 27, 2026
arrow
Subscribe Now